← Leaderboards
Vanni Bucci
Univ Of Massachusetts Med Sch Worcester
$2,397,148
Attributed
$4,329,556
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,329,556 · 3
By mechanism
R01$2,107,076 · 1
U01$1,757,741 · 1
R15$464,739 · 1
Top collaborators
- John Patrick Haran3 shared
- Beth A Mccormick3 shared
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- Raffi V Aroian$19,935,756
- Benjamin Fidelius Sallis$149,626
- Beth A McCormick$17,465,257
- John Patrick Haran$6,446,934
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroResistanceMicrobiomeIntestinesInfectionBacteriaAntibioticsMicrobiome TherapeuticsEpitheliumInflammatoryHomeostasisSamplingGut ColonizationGut MicrobiomeDysbiosisIn VivoIntestinal EpitheliumMicrobeMetagenomicsMicrobialPathogenGut MicrobiotaMathematical ModelCost
Grant awards (7)
Aging Microbiome, Immunosenescence, and risk of Multi-drug Resistant Organism Colonization and Infection in the Nursing Home$688,007
R01 · FY2025 · AG
Development of targeted microbiome therapeutics and dietary interventions for potent intestinal barrier promotion to minimize GI-ARS$568,565
U01 · FY2025 · AI · contact PI
Aging Microbiome, Immunosenescence, and risk of Multi-drug Resistant Organism Colonization and Infection in the Nursing Home$700,886
R01 · FY2024 · AG
Development of targeted microbiome therapeutics and dietary interventions for potent intestinal barrier promotion to minimize GI-ARS$587,600
U01 · FY2024 · AI · contact PI
Aging Microbiome, Immunosenescence, and risk of Multi-drug Resistant Organism Colonization and Infection in the Nursing Home$718,183
R01 · FY2023 · AG
Development of targeted microbiome therapeutics and dietary interventions for potent intestinal barrier promotion to minimize GI-ARS$601,576
U01 · FY2023 · AI · contact PI
Mathematical modeling from metagenomics - minimizing risk of enteric infections$464,739
R15 · FY2015 · AI · contact PI